Hemoglobinopathy Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: H791AB7D719AEN
Market Monitor Global

Abstracts

Hemoglobinopathies are a diverse set of congenital blood ailments that are a consequence of disparities in the structure and/or synthesis of hemoglobin. Hemoglobinopathies are genetic single-gene disorders that lead to an abnormal structure of one of the globin chains of the hemoglobin molecule, rendering it unable to carry oxygen through the body, which leads to anemia or other medical abnormalities. The most common hemoglobinopathies are sickle cell disease, alpha thalassemia, and beta thalassemia.

This report contains market size and forecasts of Hemoglobinopathy in Global, including the following market information:

Global Hemoglobinopathy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hemoglobinopathy market was valued at 277.8 million in 2021 and is projected to reach US$ 372.6 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sickle Cell Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemoglobinopathy include Abbott Diagnostics, Bio-Rad Laboratories, Danaher Corporation, Mindray Medical International, Nexcelom Bioscience, Nihon Kohden, PerkinElmer, Siemens Healthineers and Sysmex Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemoglobinopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemoglobinopathy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hemoglobinopathy Market Segment Percentages, by Type, 2021 (%)

• Sickle Cell Disease
• Alpha Thalassemia
• Beta Thalassemia

Global Hemoglobinopathy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hemoglobinopathy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Laboratories
• Clinics

Global Hemoglobinopathy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hemoglobinopathy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemoglobinopathy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hemoglobinopathy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Diagnostics
• Bio-Rad Laboratories
• Danaher Corporation
• Mindray Medical International
• Nexcelom Bioscience
• Nihon Kohden
• PerkinElmer
• Siemens Healthineers
• Sysmex Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemoglobinopathy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemoglobinopathy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMOGLOBINOPATHY OVERALL MARKET SIZE

2.1 Global Hemoglobinopathy Market Size: 2021 VS 2028
2.2 Global Hemoglobinopathy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemoglobinopathy Players in Global Market
3.2 Top Global Hemoglobinopathy Companies Ranked by Revenue
3.3 Global Hemoglobinopathy Revenue by Companies
3.4 Top 3 and Top 5 Hemoglobinopathy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemoglobinopathy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathy Players in Global Market
  3.6.1 List of Global Tier 1 Hemoglobinopathy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hemoglobinopathy Market Size Markets, 2021 & 2028
  4.1.2 Sickle Cell Disease
  4.1.3 Alpha Thalassemia
  4.1.4 Beta Thalassemia
4.2 By Type - Global Hemoglobinopathy Revenue & Forecasts
  4.2.1 By Type - Global Hemoglobinopathy Revenue, 2017-2022
  4.2.2 By Type - Global Hemoglobinopathy Revenue, 2023-2028
  4.2.3 By Type - Global Hemoglobinopathy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemoglobinopathy Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Clinics
5.2 By Application - Global Hemoglobinopathy Revenue & Forecasts
  5.2.1 By Application - Global Hemoglobinopathy Revenue, 2017-2022
  5.2.2 By Application - Global Hemoglobinopathy Revenue, 2023-2028
  5.2.3 By Application - Global Hemoglobinopathy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hemoglobinopathy Market Size, 2021 & 2028
6.2 By Region - Global Hemoglobinopathy Revenue & Forecasts
  6.2.1 By Region - Global Hemoglobinopathy Revenue, 2017-2022
  6.2.2 By Region - Global Hemoglobinopathy Revenue, 2023-2028
  6.2.3 By Region - Global Hemoglobinopathy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hemoglobinopathy Revenue, 2017-2028
  6.3.2 US Hemoglobinopathy Market Size, 2017-2028
  6.3.3 Canada Hemoglobinopathy Market Size, 2017-2028
  6.3.4 Mexico Hemoglobinopathy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hemoglobinopathy Revenue, 2017-2028
  6.4.2 Germany Hemoglobinopathy Market Size, 2017-2028
  6.4.3 France Hemoglobinopathy Market Size, 2017-2028
  6.4.4 U.K. Hemoglobinopathy Market Size, 2017-2028
  6.4.5 Italy Hemoglobinopathy Market Size, 2017-2028
  6.4.6 Russia Hemoglobinopathy Market Size, 2017-2028
  6.4.7 Nordic Countries Hemoglobinopathy Market Size, 2017-2028
  6.4.8 Benelux Hemoglobinopathy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hemoglobinopathy Revenue, 2017-2028
  6.5.2 China Hemoglobinopathy Market Size, 2017-2028
  6.5.3 Japan Hemoglobinopathy Market Size, 2017-2028
  6.5.4 South Korea Hemoglobinopathy Market Size, 2017-2028
  6.5.5 Southeast Asia Hemoglobinopathy Market Size, 2017-2028
  6.5.6 India Hemoglobinopathy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hemoglobinopathy Revenue, 2017-2028
  6.6.2 Brazil Hemoglobinopathy Market Size, 2017-2028
  6.6.3 Argentina Hemoglobinopathy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemoglobinopathy Revenue, 2017-2028
  6.7.2 Turkey Hemoglobinopathy Market Size, 2017-2028
  6.7.3 Israel Hemoglobinopathy Market Size, 2017-2028
  6.7.4 Saudi Arabia Hemoglobinopathy Market Size, 2017-2028
  6.7.5 UAE Hemoglobinopathy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Diagnostics
  7.1.1 Abbott Diagnostics Corporate Summary
  7.1.2 Abbott Diagnostics Business Overview
  7.1.3 Abbott Diagnostics Hemoglobinopathy Major Product Offerings
  7.1.4 Abbott Diagnostics Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.1.5 Abbott Diagnostics Key News
7.2 Bio-Rad Laboratories
  7.2.1 Bio-Rad Laboratories Corporate Summary
  7.2.2 Bio-Rad Laboratories Business Overview
  7.2.3 Bio-Rad Laboratories Hemoglobinopathy Major Product Offerings
  7.2.4 Bio-Rad Laboratories Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.2.5 Bio-Rad Laboratories Key News
7.3 Danaher Corporation
  7.3.1 Danaher Corporation Corporate Summary
  7.3.2 Danaher Corporation Business Overview
  7.3.3 Danaher Corporation Hemoglobinopathy Major Product Offerings
  7.3.4 Danaher Corporation Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.3.5 Danaher Corporation Key News
7.4 Mindray Medical International
  7.4.1 Mindray Medical International Corporate Summary
  7.4.2 Mindray Medical International Business Overview
  7.4.3 Mindray Medical International Hemoglobinopathy Major Product Offerings
  7.4.4 Mindray Medical International Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.4.5 Mindray Medical International Key News
7.5 Nexcelom Bioscience
  7.5.1 Nexcelom Bioscience Corporate Summary
  7.5.2 Nexcelom Bioscience Business Overview
  7.5.3 Nexcelom Bioscience Hemoglobinopathy Major Product Offerings
  7.5.4 Nexcelom Bioscience Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.5.5 Nexcelom Bioscience Key News
7.6 Nihon Kohden
  7.6.1 Nihon Kohden Corporate Summary
  7.6.2 Nihon Kohden Business Overview
  7.6.3 Nihon Kohden Hemoglobinopathy Major Product Offerings
  7.6.4 Nihon Kohden Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.6.5 Nihon Kohden Key News
7.7 PerkinElmer
  7.7.1 PerkinElmer Corporate Summary
  7.7.2 PerkinElmer Business Overview
  7.7.3 PerkinElmer Hemoglobinopathy Major Product Offerings
  7.7.4 PerkinElmer Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.7.5 PerkinElmer Key News
7.8 Siemens Healthineers
  7.8.1 Siemens Healthineers Corporate Summary
  7.8.2 Siemens Healthineers Business Overview
  7.8.3 Siemens Healthineers Hemoglobinopathy Major Product Offerings
  7.8.4 Siemens Healthineers Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.8.5 Siemens Healthineers Key News
7.9 Sysmex Corporation
  7.9.1 Sysmex Corporation Corporate Summary
  7.9.2 Sysmex Corporation Business Overview
  7.9.3 Sysmex Corporation Hemoglobinopathy Major Product Offerings
  7.9.4 Sysmex Corporation Hemoglobinopathy Revenue in Global Market (2017-2022)
  7.9.5 Sysmex Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemoglobinopathy Market Opportunities & Trends in Global Market
Table 2. Hemoglobinopathy Market Drivers in Global Market
Table 3. Hemoglobinopathy Market Restraints in Global Market
Table 4. Key Players of Hemoglobinopathy in Global Market
Table 5. Top Hemoglobinopathy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemoglobinopathy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemoglobinopathy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemoglobinopathy Product Type
Table 9. List of Global Tier 1 Hemoglobinopathy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemoglobinopathy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hemoglobinopathy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemoglobinopathy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemoglobinopathy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hemoglobinopathy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemoglobinopathy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemoglobinopathy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hemoglobinopathy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemoglobinopathy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemoglobinopathy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemoglobinopathy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemoglobinopathy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemoglobinopathy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemoglobinopathy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemoglobinopathy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemoglobinopathy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemoglobinopathy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemoglobinopathy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemoglobinopathy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemoglobinopathy Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Diagnostics Corporate Summary
Table 31. Abbott Diagnostics Hemoglobinopathy Product Offerings
Table 32. Abbott Diagnostics Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 33. Bio-Rad Laboratories Corporate Summary
Table 34. Bio-Rad Laboratories Hemoglobinopathy Product Offerings
Table 35. Bio-Rad Laboratories Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 36. Danaher Corporation Corporate Summary
Table 37. Danaher Corporation Hemoglobinopathy Product Offerings
Table 38. Danaher Corporation Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 39. Mindray Medical International Corporate Summary
Table 40. Mindray Medical International Hemoglobinopathy Product Offerings
Table 41. Mindray Medical International Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 42. Nexcelom Bioscience Corporate Summary
Table 43. Nexcelom Bioscience Hemoglobinopathy Product Offerings
Table 44. Nexcelom Bioscience Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 45. Nihon Kohden Corporate Summary
Table 46. Nihon Kohden Hemoglobinopathy Product Offerings
Table 47. Nihon Kohden Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 48. PerkinElmer Corporate Summary
Table 49. PerkinElmer Hemoglobinopathy Product Offerings
Table 50. PerkinElmer Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 51. Siemens Healthineers Corporate Summary
Table 52. Siemens Healthineers Hemoglobinopathy Product Offerings
Table 53. Siemens Healthineers Hemoglobinopathy Revenue (US$, Mn), (2017-2022)
Table 54. Sysmex Corporation Corporate Summary
Table 55. Sysmex Corporation Hemoglobinopathy Product Offerings
Table 56. Sysmex Corporation Hemoglobinopathy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hemoglobinopathy Segment by Type in 2021
Figure 2. Hemoglobinopathy Segment by Application in 2021
Figure 3. Global Hemoglobinopathy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemoglobinopathy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemoglobinopathy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemoglobinopathy Revenue in 2021
Figure 8. By Type - Global Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 12. US Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 16. Germany Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 24. China Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 30. Brazil Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemoglobinopathy Revenue Market Share, 2017-2028
Figure 33. Turkey Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemoglobinopathy Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Diagnostics Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bio-Rad Laboratories Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Danaher Corporation Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mindray Medical International Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Nexcelom Bioscience Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Nihon Kohden Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. PerkinElmer Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Siemens Healthineers Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sysmex Corporation Hemoglobinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)